[3H]-RIPK1 PET tracer (Merck)

N/A

Report date: 2025/06/11 11:25:08
NME

Base Information

Drug Name[3H]-RIPK1 PET tracer (Merck)
Drug Alias Name[18F]-RIPK1 PET tracer (Merck)
ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionPositron-emission tomography enhancersReceptor-interacting serine/threonine-protein kinase 1 modulators
TargetsReceptor-interacting serine/threonine-protein kinase 1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A